Company / Revenue per Share
BioRestorative Therapies, Inc. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.05
FY2025
5-year range
$0.03 / $0.06
FY2021-FY2025
Trend
+67.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share has fluctuated over the past 10 years, ranging from $0.00 in FY2020 to $0.19 in FY2016.
Based on SEC 10-K filings.
0.05 in FY2025 with a 5-year CAGR of +98.9%.
Improved from $0.04 to $0.05 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +15.2%
- 5-Year CAGR
- +98.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, revenue per share increased 67.8% year-over-year.
- Peak revenue per share was recorded in FY2016.
- Lowest revenue per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -47.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.05 | +67.8% |
| FY2024 | $0.03 | -21.9% |
| FY2023 | $0.04 | +16.5% |
| FY2022 | $0.03 | -47.1% |
| FY2021 | $0.06 | +3749.9% |
| FY2020 | $0.00 | -82.4% |
| FY2019 | $0.01 | -28.6% |
| FY2018 | $0.01 | +71.3% |
| FY2017 | $0.01 | -95.9% |
| FY2016 | $0.19 | -22.5% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026